Filtered By:
Management: Food and Drug Administration (FDA)

This page shows you your search results in order of relevance. This is page number 10.

Order by Relevance | Date

Total 5166 results found since Jan 2013.

F.D.A. Approves First Blood Test to Detect Concussions
The test may be able to quickly identify people with suspected brain injuries that could be widely used by the Pentagon and in sports.
Source: NYT Health - February 15, 2018 Category: Consumer Health News Authors: SHEILA KAPLAN and KEN BELSON Tags: Concussions Tests (Medical) Brain Traumatic Brain Injury United States Defense and Military Forces Sports Injuries Defense Department Food and Drug Administration Source Type: news

Concussions Can Be Detected With New Blood Test Approved by F.D.A.
The test may be able to quickly identify people with suspected brain injuries that could be widely used by the Pentagon and in sports.
Source: NYT Health - February 15, 2018 Category: Consumer Health News Authors: SHEILA KAPLAN and KEN BELSON Tags: Concussions Tests (Medical) Brain Traumatic Brain Injury United States Defense and Military Forces Sports Injuries Defense Department Food and Drug Administration Source Type: news

E-Cigarette Warnings Coming To High School Bathrooms Nationwide
By Sandee LaMotte, CNN (CNN) — The US Food and Drug Administration will stage a massive education campaign aimed at the nearly 10.7 million teens at risk for e-cigarette use and potential addiction, the agency said Tuesday. For the first time, the agency will take the message that vaping is dangerous into high school bathrooms and social media feeds of those at-risk youth to stop what the FDA calls an epidemic of e-cigarette use by minors. The trend was flagged in a 2016 report from the US surgeon general, which cited a 900% increase in e-cigarette use by high school students between 2011 to 2015. More than 2 million...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 19, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News e-cigarettes FDA vaping Source Type: news

Herbal Medicine FAQs
The American Herbalists Guild is a non-profit, educational organization that promotes clinical herbalism as a viable profession rooted in ethics, competency, diversity, and freedom of practice. The AHG supports access to herbal medicine for all and advocates excellence in herbal education.The following questions and answers provide an overview of some of the most frequently asked questions.WHAT IS AN HERB?An herb is any plant or plant part used for its culinary or therapeutic value. Many of the world ' s herbal traditions also include animal and mineral substances in their practices.WHAT IS HERBAL MEDICINE?Herbal medicine ...
Source: American Herbalists Guild - An Association of Herbal Practitioners - June 2, 2013 Category: Complementary Medicine Authors: admin Source Type: news

Herbal Medicine Fundamentals
 The American Herbalists Guild, a non-profit, educational organization for the furtherance of herbalism, frequently receives questions about herbs. The following are among the most commonly asked. If any of your questions are not answered here, you may contact us for further information. WHAT IS AN HERB? Medicinally, an herb is any plant or plant part used for its therapeutic value. Yet, many of the world ' s herbal traditions also include mineral and animal substances as “herbal medicines " .WHAT IS HERBAL MEDICINE? Herbal medicine is the art and science of using herbs for promoting health and preventing and treatin...
Source: American Herbalists Guild - An Association of Herbal Practitioners - June 2, 2013 Category: Complementary Medicine Authors: admin Source Type: news

Personalized Cardiovascular Medicine Today: A Food and Drug Administration/Center for Drug Evaluation and Research Perspective.
Abstract Over the past decade, personalized medicine has received considerable attention from researchers, drug developers, and regulatory agencies. Personalized medicine includes identifying patients most likely to benefit and those most likely to experience adverse reactions in response to a drug, and tailoring therapy based on pharmacokinetics or pharmacodynamic response, as well. Perhaps most exciting is finding ways to identify likely responders through genetic, proteomic, or other tests, so that only likely responders will be treated. However, less precise methods such as identifying historical, demographic,...
Source: Circulation - October 13, 2015 Category: Cardiology Authors: Blaus A, Madabushi R, Pacanowski M, Rose M, Schuck RN, Stockbridge N, Temple R, Unger EF Tags: Circulation Source Type: research

Machines Treating Patients? It ’s Already Happening
Rayfield Byrd knows when it’s time to wake up every morning. The 68-year-old Oakland, Cal., resident hears a voice from the living room offering a cheery good morning. Except Byrd lives alone. A little after 8 a.m. each day, a small yellow robot named Mabu asks Byrd how he’s doing. Byrd has Type 2 diabetes and congestive heart failure, and about three years ago, he had surgery to implant a microvalve in his heart to keep his blood flowing properly. To stay healthy, he takes four medications a day and needs to exercise regularly. To make sure his heart is still pumping effectively, his doctor needs to stay on to...
Source: TIME: Health - March 21, 2019 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Artificial Intelligence Life Reinvented medicine Source Type: news

UCLA physician-scientist elected to National Academy of Medicine
Dr. Antoni Ribas, a world-renowned physician –scientist and professor of medicine at theDavid Geffen School of Medicine at UCLA, has been named to the National Academy of Medicine, one of the highest honors in the fields of health and medicine.New members are elected by their peers, and selection to the academy honors individuals who have demonstrated outstanding professional achievement and commitment to service and have made major contributions to the advancement of the medical sciences, health care and public health.The academy recognized Ribas for defining the mechanistic basis of how patients respond to or develop r...
Source: UCLA Newsroom: Health Sciences - October 19, 2020 Category: Universities & Medical Training Source Type: news

Molecules, Vol. 27, Pages 8670: Utilization of Physiologically Based Pharmacokinetic Modeling in Pharmacokinetic Study of Natural Medicine: An Overview
Xiaoqiang Xiang Natural medicine has been widely used for clinical treatment and health care in many countries and regions. Additionally, extracting active ingredients from traditional Chinese medicine and other natural plants, defining their chemical structure and pharmacological effects, and screening potential druggable candidates are also uprising directions in new drug research and development. Physiologically based pharmacokinetic (PBPK) modeling is a mathematical modeling technique that simulates the absorption, distribution, metabolism, and elimination of drugs in various tissues and organs in vivo based on phy...
Source: Molecules - December 8, 2022 Category: Chemistry Authors: Qiuyu Jia Qingfeng He Li Yao Min Li Jiaying Lin Zhijia Tang Xiao Zhu Xiaoqiang Xiang Tags: Review Source Type: research

Complementary and alternative medicine in multiple sclerosis
Although it is sometimes hard to define, complementary and alternative medicine (CAM) refers to health care approaches that are developed outside of mainstream and conventional medicine.1 "Complementary" and "alternative" are often used interchangeably, but there are some differences. "Complementary medicine" generally refers to using a nonmainstream approach together with conventional medicine. "Alternative medicine" refers to using a nonmainstream approach in place of conventional medicine. The boundaries between complementary and conventional medicine can overlap and even change with time. Most CAM therapies are not reg...
Source: Neurology - March 24, 2014 Category: Neurology Authors: Fox, R. J. Tags: All Immunology, All Demyelinating disease (CNS), Multiple sclerosis PATIENT PAGES Source Type: research

New HHS Guidance for Increasing Number of Buprenorphine Providers Who Can Treat OUD
Does your state allow it? The ongoing opioid epidemic  The U.S. hit a grim milestone of more than 100,000 drug overdose deaths,1 most opioid-involved, in the 12 months ending April 2021. This alarming increase underscores the critical need to expand access to effective medications for opioid use disorder (OUD), including in the hospital setting, as noted by Linker and colleagues in The Hospitalist in December, 2021.2 A brief history of buprenorphine regulation and policy Pharmacotherapy with buprenorphine, a schedule III partial opioid agonist, and methadone, a schedule II full opioid agonist, reduces overdose and all-cau...
Source: The Hospitalist - June 1, 2022 Category: Hospital Management Authors: Ronda Whitaker Tags: Addiction Medicine Advocacy Clinical Guidelines Opioid Resource Center Source Type: research

New HHS Guidance for Increasing Number of Buprenorphine Clinicians Who Can Treat OUD
Does your state allow it? The ongoing opioid epidemic  The U.S. hit a grim milestone of more than 100,000 drug overdose deaths,1 most opioid-involved, in the 12 months ending April 2021. This alarming increase underscores the critical need to expand access to effective medications for opioid use disorder (OUD), including in the hospital setting, as noted by Linker and colleagues in The Hospitalist in December, 2021.2 A brief history of buprenorphine regulation and policy Pharmacotherapy with buprenorphine, a schedule III partial opioid agonist, and methadone, a schedule II full opioid agonist, reduces overdose and all-cau...
Source: The Hospitalist - June 1, 2022 Category: Hospital Management Authors: Ronda Whitaker Tags: Addiction Medicine Advocacy Clinical Guidelines Opioid Resource Center Source Type: research

Signal Detection for Thai Traditional Medicine: Examination of National Pharmacovigilance Data Using Reporting Odds Ratio and Reported Population Attributable Risk.
This study aimed to quantify the contribution of Thai traditional medicine (TTM) to ADR reports and to assess the association between TTMs and serious adverse drug reactions. Data were retrieved from the adverse drug reaction surveillance database, Thai-Food and Drug Administration from 2002 - 2013. Crude and adjusted RORs for each drug-ADR pair and RPARs were computed. TTM contributed only 0.001% of all serious ADRs reported. Out of 4,208 TTM-ADR pairs examined, three had a statistically significant ROR, namely Andrographis paniculata and anaphylactic shock (ROR 2.32, 95%CI 1.03, 5.21); green traditional medicine and Stev...
Source: Regulatory Toxicology and Pharmacology : RTP - June 16, 2014 Category: Toxicology Authors: Wechwithan S, Suwankesawong W, Sornsrivichai V, McNeil EB, Jiraphongsa C, Chongsuvivatwong V Tags: Regul Toxicol Pharmacol Source Type: research